Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 1/20 | 0.56 |
| ▸ | F2 | P00734 | 4/20 | 0.55 |
| ▸ | NPY1R | P25929 | 1/20 | 0.52 |
| ▸ | NPY2R | P49146 | 1/20 | 0.52 |
| ▸ | NPY4R | P50391 | 1/20 | 0.52 |
| ▸ | GLP1R | P43220 | 4/20 | 0.52 |
| ▸ | NPBWR1 | P48145 | 6/20 | 0.52 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.50 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.50 |
| ▸ | QRFPR | Q96P65 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31694488 | 0.91 | C5AR1 (0.58) | C5AR1GLP1R | |
| SCHEMBL29586707 | 0.90 | C5AR1 (0.47) | C5AR1F2GLP1R | |
| SCHEMBL31031530 | 0.86 | OPRD1 (0.48) | C5AR1F2GLP1R | |
| SCHEMBL29800072 | 0.86 | F2 (0.46) | C5AR1F2GLP1RCRHR1CRHR2 | |
| SCHEMBL30536318 | 0.85 | F2 (0.58) | F2GLP1RCRHR1CRHR2 | |
| Histatin 5 SCHEMBL31694496 | 0.84 | GLP1R (0.57) | C5AR1GLP1R | |
| SCHEMBL29637838 | 0.83 | GLP1R (0.58) | F2GLP1RCRHR1CRHR2 | |
| SCHEMBL30974282 | 0.83 | OPRD1 (0.46) | C5AR1GLP1R | |
| SCHEMBL30845341 | 0.83 | C5AR1 (0.45) | C5AR1F2GLP1RNPBWR1QRFPR | |
| SCHEMBL29582481 | 0.83 | NAALAD2 (0.46) | F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE50618-E1 | Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same | PHARMAIN CORPORATION (US) | 2025-10-07 | — | — | US | disclosed |
| US-20250185669-A1 | ANTI-VIRAL PAINTS AND COATINGS AND ARTICLES COMPRISING SAME | Reactive Surfaces Ltd., LLP (US) | 2025-06-12 | — | — | US | disclosed |
| US-12232498-B2 | Anti-viral paints and coatings and articles comprising same | Reactive Surfaces Ltd., LLP (US) | 2025-02-25 | — | — | US | disclosed |
| US-20240172762-A1 | ANTI-VIRAL PAINTS AND COATINGS AND ARTICLES COMPRISING SAME | Reactive Surfaces Ltd., LLP (US) | 2024-05-30 | — | — | US | disclosed |
| US-11980192-B2 | Anti-viral paints and coatings and articles comprising same | Reactive Surfaces Ltd., LLP (US) | 2024-05-14 | — | — | US | disclosed |
| EP-3287781-B1 | A NONINVASIVE METHOD FOR MEASURING ANTIMICROBIAL PEPTIDES FROM SKIN AS AN OBJECTIVE MEASUREMENT OF NATURAL PROTECTION FROM MICROBES | PROCTER & GAMBLE (US) | 2024-04-17 | — | — | EP | disclosed |
| US-20240016160-A1 | ANTI-VIRAL PAINTS AND COATINGS AND ARTICLES COMPRISING SAME | Reactive Surfaces Ltd., LLP (US) | 2024-01-18 | — | — | US | disclosed |
| US-11832617-B2 | Anti-viral paints and coatings and articles comprising same | Reactive Surfaces Ltd., LLP (US) | 2023-12-05 | — | — | US | disclosed |
| US-11832616-B2 | Anti-viral paints and coatings and articles comprising same | Reactive Surfaces Ltd., LLP (US) | 2023-12-05 | — | — | US | disclosed |
| US-11821902-B2 | Quantitative peptide or protein assay | PIERCE BIOTECHNOLOGY, INC. (US) | 2023-11-21 | — | — | US | disclosed |
| US-20230270118-A1 | ANTI-VIRAL PAINTS AND COATINGS AND ARTICLES COMPRISING SAME | Reactive Surfaces Ltd., LLP (US) | 2023-08-31 | — | — | US | disclosed |
| US-11304420-B2 | Anti-viral paints and coatings and articles comprising same | Reactive Surfaces Ltd., LLP (US) | 2022-04-19 | — | — | US | disclosed |
| US-20220087267-A1 | ANTI-VIRAL PAINTS AND COATINGS AND ARTICLES COMPRISING SAME | Reactive Surfaces Ltd., LLP (US) | 2022-03-24 | — | — | US | disclosed |